Sign In
Buy GTLL
$0.0002
+0 (+0%)
At Close: Jun 03, 2026
Molson Coors Beverage Company (TAP) Presents at Goldman Sachs Global Staples Forum 2026 Transcript
12:10pm, Tuesday, 12'th May 2026
Molson Coors Beverage Company (TAP) Presents at Goldman Sachs Global Staples Forum 2026 Transcript
Wall Street's Verdict on Apollo Global After a Flurry of Dealmaking
10:10am, Tuesday, 12'th May 2026
Wall Street's verdict on Apollo Global Management (NYSE: APO | APO Price Prediction) after a week of frenzied dealmaking is unmistakably bullish.
WEST PALM BEACH, FL / ACCESS Newswire / May 12, 2026 / On This Special Day, May 12, 2026, as U.S. stock markets continue reaching historic all-time highs and investor appetite for next-generation ener
Organigram Global Q2 Earnings Call Highlights
09:07am, Tuesday, 12'th May 2026
Organigram Global NASDAQ: OGI reported a weaker second quarter for fiscal 2026, with management attributing the decline to operational issues in key product categories, softer Canadian cannabis market
S&P Global Energy Launches HorizonsAgents: Faster Intelligence on Energy Security, Expansion, and Resilience with AI
09:04am, Tuesday, 12'th May 2026
Turns Complex Energy & Sustainability Data into Decision-Ready Insights in Minutes for Banks, Investors, Project Developers and Corporates NEW YORK and LONDON and SINGAPORE, May 12, 2026 /PRNewswire/
SANTA MONICA, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- JAKKS Pacific, Inc. (NASDAQ: JAKK), a leading global manufacturer of toys and consumer products, in collaboration with Warner Bros. Discovery Glo
Virtuix Expands Global Rollout of Omni One with Canada Launch Amid Rising Demand for Immersive Gaming and Fitness
08:55am, Tuesday, 12'th May 2026
Canadian Expansion Supports Virtuix's Broader International Growth Strategy Across Immersive Gaming, XR Entertainment, and Next-Generation Connected Fitness AUSTIN, Texas, May 12, 2026 (GLOBE NEWSWIRE
BEIJING, May 12, 2026 (GLOBE NEWSWIRE) -- Global Mofy AI Limited (the “Company” or “Global Mofy”) (Nasdaq: GMM), a generative AI-driven technology solutions provider engaged in virtual content
Braiin Advances Proposed Acquisition of Home.cc with Valuation and Growth-Capital Components Totaling Approximately A$73 Million to Build AI-Native LivTech Platform for Residential Lifecycle Services, Targeting the $3+ Trillion Global Residential Lifecycle Services Market
08:15am, Tuesday, 12'th May 2026
Proposed acquisition would combine Home's embedded residential distribution, payments infrastructure and household-services platform with Braiin's AI, CXaaS and PropTech ecosystem MELBOURNE, AU AND LO
Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 20, 2026
08:00am, Tuesday, 12'th May 2026
BOULDER, Colo., May 12, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that Edgewise leadership will present at th
An Innovation Powerhouse: The initiative unites world-class experts in FoodTech, pet care, and ingredients to accelerate the transition toward a more sustainable pet food supply chain. Seeking New and
Johnson & Johnson Advances the Standard of Calcium Modification with Global Launch of Shockwave™ C2 Aero Coronary IVL Catheter
07:45am, Tuesday, 12'th May 2026
SANTA CLARA, Calif.--(BUSINESS WIRE)--Johnson & Johnson Advances the Standard of Calcium Modification with Global Launch of Shockwave™ C2 Aero Coronary IVL Catheter.
Venture Global Jumps After Earnings. Iran War Is Boosting Natural Gas Stocks.
07:20am, Tuesday, 12'th May 2026
The liquified natural gas producer reports better-than-expected revenue and earnings in the first quarter.
United Therapeutics Corporation to Present at the RBC Capital Markets Global Healthcare Conference
07:00am, Tuesday, 12'th May 2026
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) announced today that James Edgemond, Chief Financial Officer and Treasurer, will prov
VEPPANU has a novel mechanism of action, is the first and only FDA-approved PROTAC and has the potential to become an important new treatment option for adult patients with 2L+ ER+/HER2-, ESR1-mutated
